University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Thomas Vail, M.D.

Chair of Orthopedic Surgery

Dr. Thomas Parker Vail, chair of Orthopedic Surgery at UCSF, is a specialist in total joint replacement and preservation of the hip and knee and surgical treatment of arthritis and osteonecrosis. In his research, Vail focuses on innovative bone implant techniques, clinical outcomes of devices used in adult reconstruction and repair of cartilage.

As chair of Orthopedic Surgery, Vail oversees the department's clinical, research and education activities.

Read a Q&A with Vail.

Clinics

Arthritis and Joint Replacement Center
1500 Owens St.
San Francisco, CA 94158
Phone: (415) 353–2808
Fax: (415) 885–3862

Hours: Monday to Friday, 8 a.m. – 5 p.m.

Conditions & Treatments

More about Thomas Vail

Additional Languages

Spanish

Education

Loyola University School of Medicine 1985

Residencies

Duke University, Orthopaedic Surgery 1991

Fellowships

Duke University, Reconstructive/Cosmetic Surgery 1992

Selected Research and Publications

  1. Newman ET, Watters TS, Lewis JS, Jennings JM, Wellman SS, Attarian DE, Grant SA, Green CL, Vail TP, Bolognesi MP. Impact of perioperative allogeneic and autologous blood transfusion on acute wound infection following total knee and total hip arthroplasty. J Bone Joint Surg Am. 2014 Feb 19; 96(4):279-84.
  2. Bozic KJ, Lau E, Ong K, Chan V, Kurtz S, Vail TP, Rubash HE, Berry DJ. Risk factors for early revision after primary total hip arthroplasty in medicare patients. Clin Orthop Relat Res. 2014 Feb; 472(2):449-54.
  3. Schairer WW, Sing DC, Vail TP, Bozic KJ. Causes and frequency of unplanned hospital readmission after total hip arthroplasty. Clin Orthop Relat Res. 2014 Feb; 472(2):464-70.
  4. Bozic KJ, Lau E, Ong K, Chan V, Kurtz S, Vail TP, Rubash HE, Berry DJ. Risk Factors for Early Revision After Primary TKA in Medicare Patients. Clin Orthop Relat Res. 2014 Jan; 472(1):232-7.
  5. Liu C, Kakis A, Nichols A, Ries MD, Vail TP, Bozic KJ. Targeted Use of Vancomycin as Perioperative Prophylaxis Reduces Periprosthetic Joint Infection in Revision TKA. Clin Orthop Relat Res. 2014 Jan; 472(1):227-31.
  6. Bozic KJ, Ward L, Vail TP, Maze M. Bundled payments in total joint arthroplasty: targeting opportunities for quality improvement and cost reduction. Clin Orthop Relat Res. 2014 Jan; 472(1):188-93.
  7. Schairer WW, Vail TP, Bozic KJ. What are the rates and causes of hospital readmission after total knee arthroplasty? Clin Orthop Relat Res. 2014 Jan; 472(1):181-7.
  8. Vasarhelyi EM, Macdonald SJ, Della Valle CJ, Vail TP. Let's Do a Revision Total Knee Arthroplasty. Instr Course Lect. 2014; 63:239-51.
  9. Bozic KJ, Chan V, Valone FH, Feeley BT, Vail TP. Trends in hip arthroscopy utilization in the United States. J Arthroplasty. 2013 Sep; 28(8 Suppl):140-3.
  10. Subburaj K, Valentinitsch A, Dillon AB, Joseph GB, Li X, Link TM, Vail TP, Majumdar S. Regional variations in MR relaxation of hip joint cartilage in subjects with and without femoralacetabular impingement. Magn Reson Imaging. 2013 Sep; 31(7):1129-36.
  11. Lockhart PB, Garvin KL, Osmon DR, Hewlett AL, Scuderi G, Lewallen D, Vail T. The antibiotic prophylaxis guideline for prosthetic joints: trying to do the right thing. J Am Acad Orthop Surg. 2013 Mar; 21(3):193-4.
  12. Barnes CL, Vail TP, Takemoto SK. Where do knee revisions for infection, fracture, and other revisions get treated? J Arthroplasty. 2013 Mar; 28(3):423-8.
  13. Hug KT, Watters TS, Vail TP, Bolognesi MP. The withdrawn ASR™ THA and hip resurfacing systems: how have our patients fared over 1 to 6 years? Clin Orthop Relat Res. 2013 Feb; 471(2):430-8.
  14. Hug KT, Watters TS, Vail TP, Bolognesi MP. Reply to letter to the editor: the withdrawn ASR™ THA and hip resurfacing systems: how have our patients fared over 1 to 6 years? Clin Orthop Relat Res. 2013 Jan; 471(1):337.
  15. Bozic KJ, Ong K, Lau E, Berry DJ, Vail TP, Kurtz SM, Rubash HE. Estimating risk in Medicare patients with THA: an electronic risk calculator for periprosthetic joint infection and mortality. Clin Orthop Relat Res. 2013 Feb; 471(2):574-83.
  16. Queen RM, Newman ET, Abbey AN, Vail TP, Bolognesi MP. Stair ascending and descending in hip resurfacing and large head total hip arthroplasty patients. J Arthroplasty. 2013 Apr; 28(4):684-9.
  17. Bozic KJ, Lau EC, Ong KL, Vail TP, Rubash HE, Berry DJ. Comparative effectiveness of metal-on-metal and metal-on-polyethylene bearings in Medicare total hip arthroplasty patients. J Arthroplasty. 2012 Sep; 27(8 Suppl):37-40.
  18. Bozic KJ, Lau E, Kurtz S, Ong K, Rubash H, Vail TP, Berry DJ. Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients. J Bone Joint Surg Am. 2012 May 2; 94(9):794-800.
  19. Worni M, Pietrobon R, Zammar GR, Shah J, Yoo B, Maldonato M, Takemoto S, Vail TP. System dynamics to model the unintended consequences of denying payment for venous thromboembolism after total knee arthroplasty. PLoS One. 2012; 7(4):e30578.
  20. Flink BJ, Rivelli SK, Cox EA, White WD, Falcone G, Vail TP, Young CC, Bolognesi MP, Krystal AD, Trzepacz PT, Moon RE, Kwatra MM. Obstructive sleep apnea and incidence of postoperative delirium after elective knee replacement in the nondemented elderly. Anesthesiology. 2012 Apr; 116(4):788-96.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.